(Q28141776)

1

0 references

M P Leibovitch

2

0 references

L A Tintignac

3

0 references

K Pelpel

4

0 references

M Guillier

5

0 references

S A Leibovitch

Journal of Biological Chemistry

6

0 references

language of work or name

English

0 references

publication date

23 June 2000

0 references

published in

0 references

volume

275

0 references

page(s)

18767-76

0 references

issue

25

0 references

cites work

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Inhibitors of mammalian G1 cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

The brain-specific activator p35 allows Cdk5 to escape inhibition by p27Kip1 in neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Splicing into senescence: the curious case of p16 and p19ARF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Cdk inhibitors in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Expression of a single transfected cDNA converts fibroblasts to myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Identification of MRF4: a new member of the muscle regulatory factor gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Herculin, a fourth member of the MyoD family of myogenic regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

MyoD family: a paradigm for development?

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

FGF inactivates myogenic helix-loop-helix proteins through phosphorylation of a conserved protein kinase C site in their DNA-binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Cyclic AMP-dependent protein kinase inhibits the activity of myogenic helix-loop-helix proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Fibroblast growth factor inhibits MRF4 activity independently of the phosphorylation status of a conserved threonine residue within the DNA-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

The protein Id: a negative regulator of helix-loop-helix DNA binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Ectopic expression of cyclin D1 prevents activation of gene transcription by myogenic basic helix-loop-helix regulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Phosphorylation of nuclear MyoD is required for its rapid degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

cdk1- and cdk2-mediated phosphorylation of MyoD Ser200 in growing C2 myoblasts: role in modulating MyoD half-life and myogenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

p57(Kip2) stabilizes the MyoD protein by inhibiting cyclin E-Cdk2 kinase activity in growing myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Identification of a myocyte nuclear factor that binds to the muscle-specific enhancer of the mouse muscle creatine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Positive autoregulation of the myogenic determination gene MyoD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Overexpression of Mos(rat) proto-oncogene product enhances the positive autoregulatory loop of MyoD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Dimerization of the amino terminal domain of p57Kip2 inhibits cyclin D1-cdk4 kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

The muscle regulatory factors MyoD and myf-5 undergo distinct cell cycle-specific expression in muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

New functional activities for the p21 family of CDK inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Elucidating the folding problem of helical peptides using empirical parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199

Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith–Wiedemann syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M907412199